nodes	percent_of_prediction	percent_of_DWPC	metapath
SIMEPREVIR—P-Glycoprotein Inhibitors—Cyclosporine—psoriasis	0.346	0.521	CiPCiCtD
SIMEPREVIR—Cytochrome P450 3A4 Inhibitors—Cyclosporine—psoriasis	0.318	0.479	CiPCiCtD
SIMEPREVIR—ALB—Acitretin—psoriasis	0.0325	0.118	CbGbCtD
SIMEPREVIR—CYP1A2—Clobetasol propionate—psoriasis	0.0301	0.11	CbGbCtD
SIMEPREVIR—SLCO1B1—Mycophenolate mofetil—psoriasis	0.0278	0.101	CbGbCtD
SIMEPREVIR—SLCO1B1—Cyclosporine—psoriasis	0.021	0.0765	CbGbCtD
SIMEPREVIR—CYP1A2—Methoxsalen—psoriasis	0.0158	0.0576	CbGbCtD
SIMEPREVIR—ALB—Mycophenolate mofetil—psoriasis	0.0152	0.0553	CbGbCtD
SIMEPREVIR—ALB—Prednisone—psoriasis	0.0122	0.0442	CbGbCtD
SIMEPREVIR—SLCO1B1—Methotrexate—psoriasis	0.0111	0.0405	CbGbCtD
SIMEPREVIR—CYP3A4—Calcitriol—psoriasis	0.0107	0.0388	CbGbCtD
SIMEPREVIR—CYP3A4—Methoxsalen—psoriasis	0.0083	0.0302	CbGbCtD
SIMEPREVIR—ABCB1—Mycophenolate mofetil—psoriasis	0.00795	0.0289	CbGbCtD
SIMEPREVIR—ABCB1—Betamethasone—psoriasis	0.00682	0.0248	CbGbCtD
SIMEPREVIR—ABCB1—Prednisolone—psoriasis	0.00673	0.0245	CbGbCtD
SIMEPREVIR—ABCB1—Hydrocortisone—psoriasis	0.00638	0.0232	CbGbCtD
SIMEPREVIR—ABCB1—Prednisone—psoriasis	0.00636	0.0231	CbGbCtD
SIMEPREVIR—ALB—Methotrexate—psoriasis	0.0061	0.0222	CbGbCtD
SIMEPREVIR—ABCB1—Cyclosporine—psoriasis	0.00603	0.0219	CbGbCtD
SIMEPREVIR—CYP3A4—Cholecalciferol—psoriasis	0.0055	0.02	CbGbCtD
SIMEPREVIR—CYP3A4—Mycophenolate mofetil—psoriasis	0.00476	0.0173	CbGbCtD
SIMEPREVIR—CYP3A4—Triamcinolone—psoriasis	0.00476	0.0173	CbGbCtD
SIMEPREVIR—CYP3A4—Betamethasone—psoriasis	0.00409	0.0149	CbGbCtD
SIMEPREVIR—CYP3A4—Prednisolone—psoriasis	0.00403	0.0147	CbGbCtD
SIMEPREVIR—ABCB1—Dexamethasone—psoriasis	0.00397	0.0144	CbGbCtD
SIMEPREVIR—CYP3A4—Hydrocortisone—psoriasis	0.00382	0.0139	CbGbCtD
SIMEPREVIR—CYP3A4—Prednisone—psoriasis	0.00381	0.0138	CbGbCtD
SIMEPREVIR—CYP3A4—Cyclosporine—psoriasis	0.00361	0.0131	CbGbCtD
SIMEPREVIR—ABCB1—Methotrexate—psoriasis	0.00319	0.0116	CbGbCtD
SIMEPREVIR—CTSS—Endosomal/Vacuolar pathway—HLA-C—psoriasis	0.0024	0.11	CbGpPWpGaD
SIMEPREVIR—CYP3A4—Dexamethasone—psoriasis	0.00238	0.00865	CbGbCtD
SIMEPREVIR—CTSS—Endosomal/Vacuolar pathway—HLA-E—psoriasis	0.00199	0.0914	CbGpPWpGaD
SIMEPREVIR—CTSS—Endosomal/Vacuolar pathway—HLA-B—psoriasis	0.00142	0.0652	CbGpPWpGaD
SIMEPREVIR—CTSS—Endosomal/Vacuolar pathway—HLA-A—psoriasis	0.00131	0.0604	CbGpPWpGaD
SIMEPREVIR—Photosensitivity reaction—Tazarotene—psoriasis	0.000855	0.0217	CcSEcCtD
SIMEPREVIR—Photosensitivity—Acitretin—psoriasis	0.000591	0.015	CcSEcCtD
SIMEPREVIR—Hyperbilirubinaemia—Mycophenolic acid—psoriasis	0.000517	0.0131	CcSEcCtD
SIMEPREVIR—Photosensitivity reaction—Methoxsalen—psoriasis	0.000516	0.0131	CcSEcCtD
SIMEPREVIR—Pruritus—Calcipotriol—psoriasis	0.000511	0.013	CcSEcCtD
SIMEPREVIR—CTSS—Antigen processing-Cross presentation—HLA-C—psoriasis	0.00049	0.0225	CbGpPWpGaD
SIMEPREVIR—Unspecified disorder of skin and subcutaneous tissue—Clobetasol propionate—psoriasis	0.000468	0.0119	CcSEcCtD
SIMEPREVIR—Rash—Calcipotriol—psoriasis	0.000456	0.0116	CcSEcCtD
SIMEPREVIR—Dermatitis—Calcipotriol—psoriasis	0.000455	0.0116	CcSEcCtD
SIMEPREVIR—Infection—Clobetasol propionate—psoriasis	0.000449	0.0114	CcSEcCtD
SIMEPREVIR—Skin disorder—Clobetasol propionate—psoriasis	0.000439	0.0112	CcSEcCtD
SIMEPREVIR—ABCB1—Allograft Rejection—IL22—psoriasis	0.000431	0.0198	CbGpPWpGaD
SIMEPREVIR—CYP1A2—Xenobiotics—CYP2S1—psoriasis	0.000429	0.0197	CbGpPWpGaD
SIMEPREVIR—Unspecified disorder of skin and subcutaneous tissue—Fluocinonide—psoriasis	0.000422	0.0107	CcSEcCtD
SIMEPREVIR—Hyperbilirubinaemia—Cyclosporine—psoriasis	0.000418	0.0106	CcSEcCtD
SIMEPREVIR—Photosensitivity reaction—Acitretin—psoriasis	0.000409	0.0104	CcSEcCtD
SIMEPREVIR—Infection—Beclomethasone—psoriasis	0.000408	0.0104	CcSEcCtD
SIMEPREVIR—Hyperbilirubinaemia—Mycophenolate mofetil—psoriasis	0.000408	0.0104	CcSEcCtD
SIMEPREVIR—CTSS—Antigen processing-Cross presentation—HLA-E—psoriasis	0.000407	0.0187	CbGpPWpGaD
SIMEPREVIR—Infection—Fluocinonide—psoriasis	0.000405	0.0103	CcSEcCtD
SIMEPREVIR—Skin disorder—Fluocinonide—psoriasis	0.000396	0.0101	CcSEcCtD
SIMEPREVIR—Pruritus—Tazarotene—psoriasis	0.000377	0.00958	CcSEcCtD
SIMEPREVIR—SLCO1B1—Drug Induction of Bile Acid Pathway—VDR—psoriasis	0.000356	0.0164	CbGpPWpGaD
SIMEPREVIR—CTSS—Class I MHC mediated antigen processing & presentation—ERAP1—psoriasis	0.000341	0.0157	CbGpPWpGaD
SIMEPREVIR—Rash—Tazarotene—psoriasis	0.000336	0.00854	CcSEcCtD
SIMEPREVIR—Dermatitis—Tazarotene—psoriasis	0.000336	0.00853	CcSEcCtD
SIMEPREVIR—CYP3A4—Xenobiotics—CYP2S1—psoriasis	0.000331	0.0152	CbGpPWpGaD
SIMEPREVIR—CTSS—Adaptive Immune System—KIR2DS1—psoriasis	0.00033	0.0151	CbGpPWpGaD
SIMEPREVIR—Mediastinal disorder—Fluocinolone Acetonide—psoriasis	0.000322	0.0082	CcSEcCtD
SIMEPREVIR—Pruritus—Clobetasol propionate—psoriasis	0.000319	0.00812	CcSEcCtD
SIMEPREVIR—Infection—Methoxsalen—psoriasis	0.000319	0.00812	CcSEcCtD
SIMEPREVIR—Skin disorder—Methoxsalen—psoriasis	0.000312	0.00794	CcSEcCtD
SIMEPREVIR—Myalgia—Calcitriol—psoriasis	0.000299	0.0076	CcSEcCtD
SIMEPREVIR—Hepatobiliary disease—Hydroxyurea—psoriasis	0.000297	0.00754	CcSEcCtD
SIMEPREVIR—Insomnia—Methoxsalen—psoriasis	0.000291	0.00739	CcSEcCtD
SIMEPREVIR—CTSS—Antigen processing-Cross presentation—HLA-B—psoriasis	0.00029	0.0133	CbGpPWpGaD
SIMEPREVIR—Pruritus—Fluocinonide—psoriasis	0.000288	0.00733	CcSEcCtD
SIMEPREVIR—Rash—Clobetasol propionate—psoriasis	0.000285	0.00724	CcSEcCtD
SIMEPREVIR—Dermatitis—Clobetasol propionate—psoriasis	0.000284	0.00723	CcSEcCtD
SIMEPREVIR—Headache—Clobetasol propionate—psoriasis	0.000283	0.00719	CcSEcCtD
SIMEPREVIR—Skin disorder—Calcitriol—psoriasis	0.000278	0.00708	CcSEcCtD
SIMEPREVIR—Gastrointestinal disorder—Methoxsalen—psoriasis	0.000278	0.00706	CcSEcCtD
SIMEPREVIR—CTSS—Antigen processing-Cross presentation—HLA-A—psoriasis	0.000269	0.0123	CbGpPWpGaD
SIMEPREVIR—Myalgia—Acitretin—psoriasis	0.000266	0.00676	CcSEcCtD
SIMEPREVIR—Musculoskeletal discomfort—Calcitriol—psoriasis	0.000261	0.00664	CcSEcCtD
SIMEPREVIR—Rash—Beclomethasone—psoriasis	0.000259	0.00659	CcSEcCtD
SIMEPREVIR—Insomnia—Calcitriol—psoriasis	0.000259	0.00659	CcSEcCtD
SIMEPREVIR—Dermatitis—Beclomethasone—psoriasis	0.000259	0.00658	CcSEcCtD
SIMEPREVIR—Headache—Beclomethasone—psoriasis	0.000258	0.00655	CcSEcCtD
SIMEPREVIR—Rash—Fluocinonide—psoriasis	0.000257	0.00653	CcSEcCtD
SIMEPREVIR—Dermatitis—Fluocinonide—psoriasis	0.000257	0.00652	CcSEcCtD
SIMEPREVIR—Headache—Fluocinonide—psoriasis	0.000255	0.00649	CcSEcCtD
SIMEPREVIR—Infection—Acitretin—psoriasis	0.000253	0.00644	CcSEcCtD
SIMEPREVIR—Infection—Fluocinolone Acetonide—psoriasis	0.000253	0.00642	CcSEcCtD
SIMEPREVIR—Hepatobiliary disease—Mycophenolic acid—psoriasis	0.000249	0.00632	CcSEcCtD
SIMEPREVIR—Skin disorder—Acitretin—psoriasis	0.000248	0.00629	CcSEcCtD
SIMEPREVIR—Constipation—Calcitriol—psoriasis	0.000245	0.00623	CcSEcCtD
SIMEPREVIR—Nausea—Beclomethasone—psoriasis	0.000244	0.00621	CcSEcCtD
SIMEPREVIR—Musculoskeletal discomfort—Acitretin—psoriasis	0.000232	0.0059	CcSEcCtD
SIMEPREVIR—Musculoskeletal discomfort—Fluocinolone Acetonide—psoriasis	0.000232	0.00589	CcSEcCtD
SIMEPREVIR—Hyperbilirubinaemia—Methotrexate—psoriasis	0.000231	0.00587	CcSEcCtD
SIMEPREVIR—Insomnia—Acitretin—psoriasis	0.000231	0.00586	CcSEcCtD
SIMEPREVIR—Pruritus—Methoxsalen—psoriasis	0.000227	0.00578	CcSEcCtD
SIMEPREVIR—Anaemia—Hydroxyurea—psoriasis	0.000227	0.00576	CcSEcCtD
SIMEPREVIR—Gastrointestinal disorder—Acitretin—psoriasis	0.00022	0.0056	CcSEcCtD
SIMEPREVIR—Fatigue—Acitretin—psoriasis	0.00022	0.00559	CcSEcCtD
SIMEPREVIR—Gastrointestinal disorder—Fluocinolone Acetonide—psoriasis	0.000219	0.00558	CcSEcCtD
SIMEPREVIR—CTSS—Extracellular matrix organization—ITGAL—psoriasis	0.000219	0.0101	CbGpPWpGaD
SIMEPREVIR—Constipation—Acitretin—psoriasis	0.000218	0.00554	CcSEcCtD
SIMEPREVIR—CTSS—Toll-Like Receptors Cascades—SOCS1—psoriasis	0.000216	0.00992	CbGpPWpGaD
SIMEPREVIR—Mediastinal disorder—Mycophenolic acid—psoriasis	0.000213	0.00541	CcSEcCtD
SIMEPREVIR—Unspecified disorder of skin and subcutaneous tissue—Hydroxyurea—psoriasis	0.000207	0.00527	CcSEcCtD
SIMEPREVIR—Asthenia—Calcitriol—psoriasis	0.000206	0.00523	CcSEcCtD
SIMEPREVIR—Pruritus—Calcitriol—psoriasis	0.000203	0.00515	CcSEcCtD
SIMEPREVIR—Rash—Methoxsalen—psoriasis	0.000203	0.00515	CcSEcCtD
SIMEPREVIR—Dermatitis—Methoxsalen—psoriasis	0.000203	0.00515	CcSEcCtD
SIMEPREVIR—CTSS—MHC class II antigen presentation—HLA-DRB1—psoriasis	0.000202	0.00929	CbGpPWpGaD
SIMEPREVIR—Headache—Methoxsalen—psoriasis	0.000201	0.00512	CcSEcCtD
SIMEPREVIR—Hepatobiliary disease—Cyclosporine—psoriasis	0.000201	0.00511	CcSEcCtD
SIMEPREVIR—CTSS—Immune System—KIR2DS1—psoriasis	0.0002	0.00919	CbGpPWpGaD
SIMEPREVIR—Infection—Hydroxyurea—psoriasis	0.000199	0.00505	CcSEcCtD
SIMEPREVIR—Hepatobiliary disease—Mycophenolate mofetil—psoriasis	0.000196	0.00499	CcSEcCtD
SIMEPREVIR—CTSS—Class I MHC mediated antigen processing & presentation—HLA-C—psoriasis	0.000196	0.009	CbGpPWpGaD
SIMEPREVIR—Skin disorder—Hydroxyurea—psoriasis	0.000194	0.00494	CcSEcCtD
SIMEPREVIR—Nausea—Methoxsalen—psoriasis	0.000191	0.00485	CcSEcCtD
SIMEPREVIR—Anaemia—Mycophenolic acid—psoriasis	0.00019	0.00483	CcSEcCtD
SIMEPREVIR—Asthenia—Acitretin—psoriasis	0.000183	0.00465	CcSEcCtD
SIMEPREVIR—Rash—Calcitriol—psoriasis	0.000181	0.00459	CcSEcCtD
SIMEPREVIR—Dermatitis—Calcitriol—psoriasis	0.000181	0.00459	CcSEcCtD
SIMEPREVIR—Pruritus—Acitretin—psoriasis	0.00018	0.00459	CcSEcCtD
SIMEPREVIR—ALB—HDL-mediated lipid transport—APOE—psoriasis	0.00018	0.00827	CbGpPWpGaD
SIMEPREVIR—Pruritus—Fluocinolone Acetonide—psoriasis	0.00018	0.00457	CcSEcCtD
SIMEPREVIR—Headache—Calcitriol—psoriasis	0.00018	0.00456	CcSEcCtD
SIMEPREVIR—Dyspnoea—Hydroxyurea—psoriasis	0.000178	0.00454	CcSEcCtD
SIMEPREVIR—ABCB1—Drug Induction of Bile Acid Pathway—VDR—psoriasis	0.000178	0.00819	CbGpPWpGaD
SIMEPREVIR—CYP1A2—Cytochrome P450 - arranged by substrate type—CYP2S1—psoriasis	0.000178	0.00818	CbGpPWpGaD
SIMEPREVIR—CYP1A2—Oxidation by Cytochrome P450—CYP2S1—psoriasis	0.000176	0.00807	CbGpPWpGaD
SIMEPREVIR—Myalgia—Mycophenolic acid—psoriasis	0.000175	0.00445	CcSEcCtD
SIMEPREVIR—Unspecified disorder of skin and subcutaneous tissue—Mycophenolic acid—psoriasis	0.000174	0.00441	CcSEcCtD
SIMEPREVIR—Photosensitivity—Methotrexate—psoriasis	0.000174	0.00441	CcSEcCtD
SIMEPREVIR—Gastrointestinal disorder—Hydroxyurea—psoriasis	0.000173	0.00439	CcSEcCtD
SIMEPREVIR—Fatigue—Hydroxyurea—psoriasis	0.000173	0.00439	CcSEcCtD
SIMEPREVIR—Mediastinal disorder—Cyclosporine—psoriasis	0.000172	0.00437	CcSEcCtD
SIMEPREVIR—Constipation—Hydroxyurea—psoriasis	0.000171	0.00435	CcSEcCtD
SIMEPREVIR—Nausea—Calcitriol—psoriasis	0.00017	0.00433	CcSEcCtD
SIMEPREVIR—CTSS—Adaptive Immune System—ERAP1—psoriasis	0.000169	0.00775	CbGpPWpGaD
SIMEPREVIR—Mediastinal disorder—Mycophenolate mofetil—psoriasis	0.000168	0.00427	CcSEcCtD
SIMEPREVIR—Infection—Mycophenolic acid—psoriasis	0.000167	0.00423	CcSEcCtD
SIMEPREVIR—Skin disorder—Mycophenolic acid—psoriasis	0.000163	0.00414	CcSEcCtD
SIMEPREVIR—CTSS—Class I MHC mediated antigen processing & presentation—HLA-E—psoriasis	0.000163	0.00747	CbGpPWpGaD
SIMEPREVIR—Rash—Acitretin—psoriasis	0.000161	0.00409	CcSEcCtD
SIMEPREVIR—Dermatitis—Acitretin—psoriasis	0.000161	0.00408	CcSEcCtD
SIMEPREVIR—Rash—Fluocinolone Acetonide—psoriasis	0.00016	0.00407	CcSEcCtD
SIMEPREVIR—Dermatitis—Fluocinolone Acetonide—psoriasis	0.00016	0.00407	CcSEcCtD
SIMEPREVIR—Headache—Acitretin—psoriasis	0.00016	0.00406	CcSEcCtD
SIMEPREVIR—Headache—Fluocinolone Acetonide—psoriasis	0.000159	0.00405	CcSEcCtD
SIMEPREVIR—CTSS—Innate Immune System—DDX58—psoriasis	0.000155	0.00711	CbGpPWpGaD
SIMEPREVIR—Anaemia—Cyclosporine—psoriasis	0.000154	0.0039	CcSEcCtD
SIMEPREVIR—Musculoskeletal discomfort—Mycophenolic acid—psoriasis	0.000153	0.00388	CcSEcCtD
SIMEPREVIR—Insomnia—Mycophenolic acid—psoriasis	0.000152	0.00385	CcSEcCtD
SIMEPREVIR—Nausea—Acitretin—psoriasis	0.000151	0.00385	CcSEcCtD
SIMEPREVIR—Nausea—Fluocinolone Acetonide—psoriasis	0.000151	0.00384	CcSEcCtD
SIMEPREVIR—Anaemia—Mycophenolate mofetil—psoriasis	0.00015	0.00381	CcSEcCtD
SIMEPREVIR—Dyspnoea—Mycophenolic acid—psoriasis	0.000149	0.0038	CcSEcCtD
SIMEPREVIR—CTSS—Toll-Like Receptors Cascades—NFKBIA—psoriasis	0.000149	0.00682	CbGpPWpGaD
SIMEPREVIR—Gastrointestinal disorder—Mycophenolic acid—psoriasis	0.000145	0.00368	CcSEcCtD
SIMEPREVIR—Fatigue—Mycophenolic acid—psoriasis	0.000145	0.00367	CcSEcCtD
SIMEPREVIR—CYP1A2—Phase 1 - Functionalization of compounds—CYP2S1—psoriasis	0.000144	0.00663	CbGpPWpGaD
SIMEPREVIR—Asthenia—Hydroxyurea—psoriasis	0.000144	0.00365	CcSEcCtD
SIMEPREVIR—Constipation—Mycophenolic acid—psoriasis	0.000143	0.00364	CcSEcCtD
SIMEPREVIR—Myalgia—Cyclosporine—psoriasis	0.000141	0.0036	CcSEcCtD
SIMEPREVIR—Unspecified disorder of skin and subcutaneous tissue—Cyclosporine—psoriasis	0.00014	0.00357	CcSEcCtD
SIMEPREVIR—Myalgia—Mycophenolate mofetil—psoriasis	0.000138	0.00351	CcSEcCtD
SIMEPREVIR—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2S1—psoriasis	0.000137	0.00631	CbGpPWpGaD
SIMEPREVIR—Unspecified disorder of skin and subcutaneous tissue—Mycophenolate mofetil—psoriasis	0.000137	0.00348	CcSEcCtD
SIMEPREVIR—CTSS—Class I MHC mediated antigen processing & presentation—SOCS1—psoriasis	0.000136	0.00624	CbGpPWpGaD
SIMEPREVIR—CYP3A4—Oxidation by Cytochrome P450—CYP2S1—psoriasis	0.000136	0.00623	CbGpPWpGaD
SIMEPREVIR—Infection—Cyclosporine—psoriasis	0.000135	0.00343	CcSEcCtD
SIMEPREVIR—Skin disorder—Cyclosporine—psoriasis	0.000132	0.00335	CcSEcCtD
SIMEPREVIR—Infection—Mycophenolate mofetil—psoriasis	0.000131	0.00334	CcSEcCtD
SIMEPREVIR—Skin disorder—Mycophenolate mofetil—psoriasis	0.000128	0.00327	CcSEcCtD
SIMEPREVIR—Rash—Hydroxyurea—psoriasis	0.000126	0.00321	CcSEcCtD
SIMEPREVIR—Dermatitis—Hydroxyurea—psoriasis	0.000126	0.00321	CcSEcCtD
SIMEPREVIR—Myalgia—Hydrocortisone—psoriasis	0.000126	0.0032	CcSEcCtD
SIMEPREVIR—Headache—Hydroxyurea—psoriasis	0.000125	0.00319	CcSEcCtD
SIMEPREVIR—Unspecified disorder of skin and subcutaneous tissue—Hydrocortisone—psoriasis	0.000125	0.00317	CcSEcCtD
SIMEPREVIR—Musculoskeletal discomfort—Cyclosporine—psoriasis	0.000124	0.00314	CcSEcCtD
SIMEPREVIR—Insomnia—Cyclosporine—psoriasis	0.000123	0.00312	CcSEcCtD
SIMEPREVIR—CTSS—Toll-Like Receptors Cascades—TYK2—psoriasis	0.000122	0.00559	CbGpPWpGaD
SIMEPREVIR—Dyspnoea—Cyclosporine—psoriasis	0.000121	0.00307	CcSEcCtD
SIMEPREVIR—Musculoskeletal discomfort—Mycophenolate mofetil—psoriasis	0.000121	0.00306	CcSEcCtD
SIMEPREVIR—Photosensitivity reaction—Methotrexate—psoriasis	0.00012	0.00306	CcSEcCtD
SIMEPREVIR—Asthenia—Mycophenolic acid—psoriasis	0.00012	0.00306	CcSEcCtD
SIMEPREVIR—Infection—Hydrocortisone—psoriasis	0.00012	0.00304	CcSEcCtD
SIMEPREVIR—Insomnia—Mycophenolate mofetil—psoriasis	0.00012	0.00304	CcSEcCtD
SIMEPREVIR—Nausea—Hydroxyurea—psoriasis	0.000119	0.00302	CcSEcCtD
SIMEPREVIR—Pruritus—Mycophenolic acid—psoriasis	0.000119	0.00301	CcSEcCtD
SIMEPREVIR—Myalgia—Triamcinolone—psoriasis	0.000118	0.00301	CcSEcCtD
SIMEPREVIR—Dyspnoea—Mycophenolate mofetil—psoriasis	0.000118	0.003	CcSEcCtD
SIMEPREVIR—Gastrointestinal disorder—Cyclosporine—psoriasis	0.000117	0.00298	CcSEcCtD
SIMEPREVIR—Skin disorder—Hydrocortisone—psoriasis	0.000117	0.00298	CcSEcCtD
SIMEPREVIR—Fatigue—Cyclosporine—psoriasis	0.000117	0.00297	CcSEcCtD
SIMEPREVIR—Constipation—Cyclosporine—psoriasis	0.000116	0.00295	CcSEcCtD
SIMEPREVIR—CTSS—Class I MHC mediated antigen processing & presentation—HLA-B—psoriasis	0.000116	0.00532	CbGpPWpGaD
SIMEPREVIR—Gastrointestinal disorder—Mycophenolate mofetil—psoriasis	0.000114	0.0029	CcSEcCtD
SIMEPREVIR—Constipation—Mycophenolate mofetil—psoriasis	0.000113	0.00288	CcSEcCtD
SIMEPREVIR—Infection—Triamcinolone—psoriasis	0.000113	0.00287	CcSEcCtD
SIMEPREVIR—CTSS—Adaptive Immune System—ITGAL—psoriasis	0.000113	0.00517	CbGpPWpGaD
SIMEPREVIR—Insomnia—Prednisolone—psoriasis	0.000112	0.00284	CcSEcCtD
SIMEPREVIR—CYP3A4—Phase 1 - Functionalization of compounds—CYP2S1—psoriasis	0.000111	0.00512	CbGpPWpGaD
SIMEPREVIR—Hepatobiliary disease—Methotrexate—psoriasis	0.000111	0.00283	CcSEcCtD
SIMEPREVIR—CYP3A4—Drug Induction of Bile Acid Pathway—VDR—psoriasis	0.00011	0.00505	CbGpPWpGaD
SIMEPREVIR—Musculoskeletal discomfort—Hydrocortisone—psoriasis	0.00011	0.00279	CcSEcCtD
SIMEPREVIR—Insomnia—Hydrocortisone—psoriasis	0.000109	0.00277	CcSEcCtD
SIMEPREVIR—Myalgia—Dexamethasone—psoriasis	0.000107	0.00273	CcSEcCtD
SIMEPREVIR—Myalgia—Betamethasone—psoriasis	0.000107	0.00273	CcSEcCtD
SIMEPREVIR—CTSS—Class I MHC mediated antigen processing & presentation—HLA-A—psoriasis	0.000107	0.00493	CbGpPWpGaD
SIMEPREVIR—CTSS—Innate Immune System—IFIH1—psoriasis	0.000106	0.00489	CbGpPWpGaD
SIMEPREVIR—ABCB1—HIF-1-alpha transcription factor network—CP—psoriasis	0.000106	0.00486	CbGpPWpGaD
SIMEPREVIR—Rash—Mycophenolic acid—psoriasis	0.000106	0.00269	CcSEcCtD
SIMEPREVIR—Dermatitis—Mycophenolic acid—psoriasis	0.000106	0.00268	CcSEcCtD
SIMEPREVIR—CTSS—Adaptive Immune System—REL—psoriasis	0.000105	0.00484	CbGpPWpGaD
SIMEPREVIR—Headache—Mycophenolic acid—psoriasis	0.000105	0.00267	CcSEcCtD
SIMEPREVIR—Gastrointestinal disorder—Hydrocortisone—psoriasis	0.000104	0.00265	CcSEcCtD
SIMEPREVIR—Fatigue—Hydrocortisone—psoriasis	0.000104	0.00264	CcSEcCtD
SIMEPREVIR—ALB—Lipoprotein metabolism—APOE—psoriasis	0.000103	0.00475	CbGpPWpGaD
SIMEPREVIR—Musculoskeletal discomfort—Triamcinolone—psoriasis	0.000103	0.00263	CcSEcCtD
SIMEPREVIR—Insomnia—Triamcinolone—psoriasis	0.000103	0.00261	CcSEcCtD
SIMEPREVIR—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—psoriasis	0.000102	0.00471	CbGpPWpGaD
SIMEPREVIR—CTSS—Immune System—ERAP1—psoriasis	0.000102	0.0047	CbGpPWpGaD
SIMEPREVIR—Infection—Betamethasone—psoriasis	0.000102	0.0026	CcSEcCtD
SIMEPREVIR—Infection—Dexamethasone—psoriasis	0.000102	0.0026	CcSEcCtD
SIMEPREVIR—Anaemia—Prednisone—psoriasis	0.000102	0.00258	CcSEcCtD
SIMEPREVIR—Dyspnoea—Triamcinolone—psoriasis	0.000101	0.00257	CcSEcCtD
SIMEPREVIR—CTSS—Innate Immune System—HLA-C—psoriasis	0.000101	0.00464	CbGpPWpGaD
SIMEPREVIR—CTSS—Innate Immune System—TNFAIP3—psoriasis	9.97e-05	0.00458	CbGpPWpGaD
SIMEPREVIR—Nausea—Mycophenolic acid—psoriasis	9.96e-05	0.00253	CcSEcCtD
SIMEPREVIR—CTSS—Toll-Like Receptors Cascades—JUN—psoriasis	9.85e-05	0.00452	CbGpPWpGaD
SIMEPREVIR—Fatigue—Triamcinolone—psoriasis	9.78e-05	0.00249	CcSEcCtD
SIMEPREVIR—Asthenia—Cyclosporine—psoriasis	9.73e-05	0.00247	CcSEcCtD
SIMEPREVIR—CTSS—Adaptive Immune System—HLA-C—psoriasis	9.69e-05	0.00445	CbGpPWpGaD
SIMEPREVIR—Pruritus—Cyclosporine—psoriasis	9.59e-05	0.00244	CcSEcCtD
SIMEPREVIR—Mediastinal disorder—Methotrexate—psoriasis	9.51e-05	0.00242	CcSEcCtD
SIMEPREVIR—Asthenia—Mycophenolate mofetil—psoriasis	9.49e-05	0.00241	CcSEcCtD
SIMEPREVIR—CTSS—Toll-Like Receptors Cascades—NFKB1—psoriasis	9.48e-05	0.00435	CbGpPWpGaD
SIMEPREVIR—Musculoskeletal discomfort—Dexamethasone—psoriasis	9.38e-05	0.00238	CcSEcCtD
SIMEPREVIR—Musculoskeletal discomfort—Betamethasone—psoriasis	9.38e-05	0.00238	CcSEcCtD
SIMEPREVIR—Pruritus—Mycophenolate mofetil—psoriasis	9.36e-05	0.00238	CcSEcCtD
SIMEPREVIR—Myalgia—Prednisone—psoriasis	9.35e-05	0.00238	CcSEcCtD
SIMEPREVIR—Insomnia—Betamethasone—psoriasis	9.31e-05	0.00237	CcSEcCtD
SIMEPREVIR—Insomnia—Dexamethasone—psoriasis	9.31e-05	0.00237	CcSEcCtD
SIMEPREVIR—Unspecified disorder of skin and subcutaneous tissue—Prednisone—psoriasis	9.29e-05	0.00236	CcSEcCtD
SIMEPREVIR—CTSS—Extracellular matrix organization—ICAM1—psoriasis	9.07e-05	0.00416	CbGpPWpGaD
SIMEPREVIR—CTSS—Immune System—DDX58—psoriasis	9.01e-05	0.00414	CbGpPWpGaD
SIMEPREVIR—Infection—Prednisone—psoriasis	8.91e-05	0.00226	CcSEcCtD
SIMEPREVIR—Gastrointestinal disorder—Dexamethasone—psoriasis	8.89e-05	0.00226	CcSEcCtD
SIMEPREVIR—Gastrointestinal disorder—Betamethasone—psoriasis	8.89e-05	0.00226	CcSEcCtD
SIMEPREVIR—Fatigue—Betamethasone—psoriasis	8.88e-05	0.00226	CcSEcCtD
SIMEPREVIR—Fatigue—Dexamethasone—psoriasis	8.88e-05	0.00226	CcSEcCtD
SIMEPREVIR—CYP1A2—Estrogen Receptor Pathway—JUN—psoriasis	8.73e-05	0.00401	CbGpPWpGaD
SIMEPREVIR—Skin disorder—Prednisone—psoriasis	8.71e-05	0.00221	CcSEcCtD
SIMEPREVIR—Asthenia—Hydrocortisone—psoriasis	8.65e-05	0.0022	CcSEcCtD
SIMEPREVIR—Rash—Cyclosporine—psoriasis	8.55e-05	0.00217	CcSEcCtD
SIMEPREVIR—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL12B—psoriasis	8.54e-05	0.00392	CbGpPWpGaD
SIMEPREVIR—Dermatitis—Cyclosporine—psoriasis	8.54e-05	0.00217	CcSEcCtD
SIMEPREVIR—Pruritus—Hydrocortisone—psoriasis	8.53e-05	0.00217	CcSEcCtD
SIMEPREVIR—Headache—Cyclosporine—psoriasis	8.5e-05	0.00216	CcSEcCtD
SIMEPREVIR—Anaemia—Methotrexate—psoriasis	8.49e-05	0.00216	CcSEcCtD
SIMEPREVIR—ALB—Hemostasis—SERPINB8—psoriasis	8.44e-05	0.00388	CbGpPWpGaD
SIMEPREVIR—CTSS—Innate Immune System—HLA-E—psoriasis	8.38e-05	0.00385	CbGpPWpGaD
SIMEPREVIR—Rash—Mycophenolate mofetil—psoriasis	8.34e-05	0.00212	CcSEcCtD
SIMEPREVIR—Dermatitis—Mycophenolate mofetil—psoriasis	8.33e-05	0.00212	CcSEcCtD
SIMEPREVIR—Headache—Mycophenolate mofetil—psoriasis	8.29e-05	0.00211	CcSEcCtD
SIMEPREVIR—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—psoriasis	8.18e-05	0.00376	CbGpPWpGaD
SIMEPREVIR—Musculoskeletal discomfort—Prednisone—psoriasis	8.17e-05	0.00208	CcSEcCtD
SIMEPREVIR—ABCB1—Allograft Rejection—HLA-C—psoriasis	8.17e-05	0.00375	CbGpPWpGaD
SIMEPREVIR—Asthenia—Triamcinolone—psoriasis	8.14e-05	0.00207	CcSEcCtD
SIMEPREVIR—ABCB1—Allograft Rejection—IL13—psoriasis	8.12e-05	0.00373	CbGpPWpGaD
SIMEPREVIR—Insomnia—Prednisone—psoriasis	8.11e-05	0.00206	CcSEcCtD
SIMEPREVIR—ALB—Binding and Uptake of Ligands by Scavenger Receptors—APOE—psoriasis	8.06e-05	0.0037	CbGpPWpGaD
SIMEPREVIR—Nausea—Cyclosporine—psoriasis	8.06e-05	0.00205	CcSEcCtD
SIMEPREVIR—CTSS—Adaptive Immune System—HLA-E—psoriasis	8.05e-05	0.0037	CbGpPWpGaD
SIMEPREVIR—Pruritus—Triamcinolone—psoriasis	8.03e-05	0.00204	CcSEcCtD
SIMEPREVIR—Nausea—Mycophenolate mofetil—psoriasis	7.86e-05	0.002	CcSEcCtD
SIMEPREVIR—Myalgia—Methotrexate—psoriasis	7.82e-05	0.00199	CcSEcCtD
SIMEPREVIR—Rash—Prednisolone—psoriasis	7.78e-05	0.00198	CcSEcCtD
SIMEPREVIR—Dermatitis—Prednisolone—psoriasis	7.77e-05	0.00198	CcSEcCtD
SIMEPREVIR—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—psoriasis	7.76e-05	0.00197	CcSEcCtD
SIMEPREVIR—Fatigue—Prednisone—psoriasis	7.73e-05	0.00197	CcSEcCtD
SIMEPREVIR—Headache—Prednisolone—psoriasis	7.73e-05	0.00197	CcSEcCtD
SIMEPREVIR—Constipation—Prednisone—psoriasis	7.67e-05	0.00195	CcSEcCtD
SIMEPREVIR—CYP1A2—Biological oxidations—CYP2S1—psoriasis	7.67e-05	0.00352	CbGpPWpGaD
SIMEPREVIR—Rash—Hydrocortisone—psoriasis	7.6e-05	0.00193	CcSEcCtD
SIMEPREVIR—Dermatitis—Hydrocortisone—psoriasis	7.59e-05	0.00193	CcSEcCtD
SIMEPREVIR—CYP1A2—Metapathway biotransformation—CYP2S1—psoriasis	7.56e-05	0.00347	CbGpPWpGaD
SIMEPREVIR—Headache—Hydrocortisone—psoriasis	7.55e-05	0.00192	CcSEcCtD
SIMEPREVIR—CYP1A2—Estrogen Receptor Pathway—STAT3—psoriasis	7.55e-05	0.00347	CbGpPWpGaD
SIMEPREVIR—ABCB1—Allograft Rejection—IL17A—psoriasis	7.47e-05	0.00343	CbGpPWpGaD
SIMEPREVIR—Infection—Methotrexate—psoriasis	7.45e-05	0.00189	CcSEcCtD
SIMEPREVIR—CYP1A2—Melatonin metabolism and effects—APOE—psoriasis	7.43e-05	0.00341	CbGpPWpGaD
SIMEPREVIR—Asthenia—Dexamethasone—psoriasis	7.39e-05	0.00188	CcSEcCtD
SIMEPREVIR—Asthenia—Betamethasone—psoriasis	7.39e-05	0.00188	CcSEcCtD
SIMEPREVIR—Nausea—Prednisolone—psoriasis	7.33e-05	0.00186	CcSEcCtD
SIMEPREVIR—Pruritus—Dexamethasone—psoriasis	7.28e-05	0.00185	CcSEcCtD
SIMEPREVIR—Pruritus—Betamethasone—psoriasis	7.28e-05	0.00185	CcSEcCtD
SIMEPREVIR—Skin disorder—Methotrexate—psoriasis	7.28e-05	0.00185	CcSEcCtD
SIMEPREVIR—Nausea—Hydrocortisone—psoriasis	7.16e-05	0.00182	CcSEcCtD
SIMEPREVIR—Rash—Triamcinolone—psoriasis	7.16e-05	0.00182	CcSEcCtD
SIMEPREVIR—Dermatitis—Triamcinolone—psoriasis	7.15e-05	0.00182	CcSEcCtD
SIMEPREVIR—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—psoriasis	7.14e-05	0.00328	CbGpPWpGaD
SIMEPREVIR—Headache—Triamcinolone—psoriasis	7.11e-05	0.00181	CcSEcCtD
SIMEPREVIR—ALB—Folate Metabolism—CAT—psoriasis	7.08e-05	0.00325	CbGpPWpGaD
SIMEPREVIR—SLCO1B1—SLC-mediated transmembrane transport—CP—psoriasis	7.06e-05	0.00324	CbGpPWpGaD
SIMEPREVIR—CTSS—Innate Immune System—SOCS1—psoriasis	7e-05	0.00321	CbGpPWpGaD
SIMEPREVIR—ABCB1—Allograft Rejection—IL12B—psoriasis	6.94e-05	0.00319	CbGpPWpGaD
SIMEPREVIR—ALB—Vitamin B12 Metabolism—CRP—psoriasis	6.91e-05	0.00318	CbGpPWpGaD
SIMEPREVIR—ALB—Lipid and lipoprotein metabolism—APOE—psoriasis	6.87e-05	0.00316	CbGpPWpGaD
SIMEPREVIR—CTSS—Immune System—ITGAL—psoriasis	6.83e-05	0.00314	CbGpPWpGaD
SIMEPREVIR—Musculoskeletal discomfort—Methotrexate—psoriasis	6.83e-05	0.00174	CcSEcCtD
SIMEPREVIR—Insomnia—Methotrexate—psoriasis	6.78e-05	0.00172	CcSEcCtD
SIMEPREVIR—ABCB1—Allograft Rejection—HLA-E—psoriasis	6.78e-05	0.00311	CbGpPWpGaD
SIMEPREVIR—ALB—Vitamin B12 Metabolism—APOE—psoriasis	6.77e-05	0.00311	CbGpPWpGaD
SIMEPREVIR—Nausea—Triamcinolone—psoriasis	6.74e-05	0.00171	CcSEcCtD
SIMEPREVIR—CTSS—Adaptive Immune System—SOCS1—psoriasis	6.72e-05	0.00309	CbGpPWpGaD
SIMEPREVIR—Dyspnoea—Methotrexate—psoriasis	6.68e-05	0.0017	CcSEcCtD
SIMEPREVIR—CYP1A2—Tryptophan metabolism—CAT—psoriasis	6.61e-05	0.00304	CbGpPWpGaD
SIMEPREVIR—ALB—Folate Metabolism—IL4—psoriasis	6.51e-05	0.00299	CbGpPWpGaD
SIMEPREVIR—Rash—Betamethasone—psoriasis	6.49e-05	0.00165	CcSEcCtD
SIMEPREVIR—Rash—Dexamethasone—psoriasis	6.49e-05	0.00165	CcSEcCtD
SIMEPREVIR—Dermatitis—Dexamethasone—psoriasis	6.49e-05	0.00165	CcSEcCtD
SIMEPREVIR—Dermatitis—Betamethasone—psoriasis	6.49e-05	0.00165	CcSEcCtD
SIMEPREVIR—Gastrointestinal disorder—Methotrexate—psoriasis	6.47e-05	0.00164	CcSEcCtD
SIMEPREVIR—Fatigue—Methotrexate—psoriasis	6.46e-05	0.00164	CcSEcCtD
SIMEPREVIR—Headache—Betamethasone—psoriasis	6.45e-05	0.00164	CcSEcCtD
SIMEPREVIR—Headache—Dexamethasone—psoriasis	6.45e-05	0.00164	CcSEcCtD
SIMEPREVIR—Asthenia—Prednisone—psoriasis	6.43e-05	0.00164	CcSEcCtD
SIMEPREVIR—CTSS—Immune System—REL—psoriasis	6.39e-05	0.00293	CbGpPWpGaD
SIMEPREVIR—ALB—Vitamin B12 Metabolism—ICAM1—psoriasis	6.35e-05	0.00292	CbGpPWpGaD
SIMEPREVIR—Pruritus—Prednisone—psoriasis	6.34e-05	0.00161	CcSEcCtD
SIMEPREVIR—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—psoriasis	6.31e-05	0.0029	CbGpPWpGaD
SIMEPREVIR—CTSS—Immune System—IFIH1—psoriasis	6.2e-05	0.00285	CbGpPWpGaD
SIMEPREVIR—Nausea—Betamethasone—psoriasis	6.12e-05	0.00155	CcSEcCtD
SIMEPREVIR—Nausea—Dexamethasone—psoriasis	6.12e-05	0.00155	CcSEcCtD
SIMEPREVIR—CTSS—Innate Immune System—HLA-B—psoriasis	5.97e-05	0.00274	CbGpPWpGaD
SIMEPREVIR—CTSS—Adaptive Immune System—CD8A—psoriasis	5.96e-05	0.00274	CbGpPWpGaD
SIMEPREVIR—CTSS—Toll-Like Receptors Cascades—IL6—psoriasis	5.95e-05	0.00273	CbGpPWpGaD
SIMEPREVIR—CYP3A4—Biological oxidations—CYP2S1—psoriasis	5.92e-05	0.00272	CbGpPWpGaD
SIMEPREVIR—CTSS—Immune System—HLA-C—psoriasis	5.88e-05	0.0027	CbGpPWpGaD
SIMEPREVIR—CYP3A4—Metapathway biotransformation—CYP2S1—psoriasis	5.84e-05	0.00268	CbGpPWpGaD
SIMEPREVIR—CTSS—Immune System—TNFAIP3—psoriasis	5.81e-05	0.00267	CbGpPWpGaD
SIMEPREVIR—CTSS—Adaptive Immune System—HLA-B—psoriasis	5.73e-05	0.00263	CbGpPWpGaD
SIMEPREVIR—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—psoriasis	5.7e-05	0.00262	CbGpPWpGaD
SIMEPREVIR—Rash—Prednisone—psoriasis	5.65e-05	0.00144	CcSEcCtD
SIMEPREVIR—Dermatitis—Prednisone—psoriasis	5.65e-05	0.00144	CcSEcCtD
SIMEPREVIR—ALB—Selenium Micronutrient Network—CAT—psoriasis	5.63e-05	0.00259	CbGpPWpGaD
SIMEPREVIR—ALB—Folate Metabolism—CRP—psoriasis	5.62e-05	0.00258	CbGpPWpGaD
SIMEPREVIR—Headache—Prednisone—psoriasis	5.62e-05	0.00143	CcSEcCtD
SIMEPREVIR—ABCB1—Integrated Pancreatic Cancer Pathway—PTTG1—psoriasis	5.61e-05	0.00258	CbGpPWpGaD
SIMEPREVIR—Asthenia—Methotrexate—psoriasis	5.38e-05	0.00137	CcSEcCtD
SIMEPREVIR—Nausea—Prednisone—psoriasis	5.33e-05	0.00135	CcSEcCtD
SIMEPREVIR—CTSS—Adaptive Immune System—HLA-A—psoriasis	5.31e-05	0.00244	CbGpPWpGaD
SIMEPREVIR—Pruritus—Methotrexate—psoriasis	5.3e-05	0.00135	CcSEcCtD
SIMEPREVIR—CTSS—Innate Immune System—CRP—psoriasis	5.28e-05	0.00242	CbGpPWpGaD
SIMEPREVIR—ALB—Folate Metabolism—ICAM1—psoriasis	5.17e-05	0.00237	CbGpPWpGaD
SIMEPREVIR—CYP3A4—Tryptophan metabolism—CAT—psoriasis	5.1e-05	0.00234	CbGpPWpGaD
SIMEPREVIR—ABCB1—Allograft Rejection—IL10—psoriasis	5.08e-05	0.00233	CbGpPWpGaD
SIMEPREVIR—ABCB1—Allograft Rejection—IL4—psoriasis	4.94e-05	0.00227	CbGpPWpGaD
SIMEPREVIR—CTSS—Immune System—HLA-E—psoriasis	4.88e-05	0.00224	CbGpPWpGaD
SIMEPREVIR—CTSS—Adaptive Immune System—HLA-DRB1—psoriasis	4.85e-05	0.00223	CbGpPWpGaD
SIMEPREVIR—ALB—Vitamin B12 Metabolism—IFNG—psoriasis	4.84e-05	0.00222	CbGpPWpGaD
SIMEPREVIR—ABCB1—Allograft Rejection—HLA-B—psoriasis	4.83e-05	0.00222	CbGpPWpGaD
SIMEPREVIR—ABCB1—HIF-1-alpha transcription factor network—LEP—psoriasis	4.82e-05	0.00222	CbGpPWpGaD
SIMEPREVIR—CTSS—Innate Immune System—NFKBIA—psoriasis	4.81e-05	0.00221	CbGpPWpGaD
SIMEPREVIR—Rash—Methotrexate—psoriasis	4.73e-05	0.0012	CcSEcCtD
SIMEPREVIR—Dermatitis—Methotrexate—psoriasis	4.72e-05	0.0012	CcSEcCtD
SIMEPREVIR—Headache—Methotrexate—psoriasis	4.69e-05	0.00119	CcSEcCtD
SIMEPREVIR—CTSS—Adaptive Immune System—ICAM1—psoriasis	4.66e-05	0.00214	CbGpPWpGaD
SIMEPREVIR—CTSS—Adaptive Immune System—NFKBIA—psoriasis	4.62e-05	0.00212	CbGpPWpGaD
SIMEPREVIR—ABCB1—HIF-1-alpha transcription factor network—NOS2—psoriasis	4.49e-05	0.00206	CbGpPWpGaD
SIMEPREVIR—ABCB1—Allograft Rejection—HLA-A—psoriasis	4.47e-05	0.00206	CbGpPWpGaD
SIMEPREVIR—ALB—Selenium Micronutrient Network—CRP—psoriasis	4.47e-05	0.00205	CbGpPWpGaD
SIMEPREVIR—Nausea—Methotrexate—psoriasis	4.45e-05	0.00113	CcSEcCtD
SIMEPREVIR—CYP1A2—Melatonin metabolism and effects—NFKB1—psoriasis	4.42e-05	0.00203	CbGpPWpGaD
SIMEPREVIR—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—psoriasis	4.4e-05	0.00202	CbGpPWpGaD
SIMEPREVIR—ALB—Selenium Micronutrient Network—ICAM1—psoriasis	4.11e-05	0.00189	CbGpPWpGaD
SIMEPREVIR—ABCB1—Allograft Rejection—HLA-DRB1—psoriasis	4.09e-05	0.00188	CbGpPWpGaD
SIMEPREVIR—CTSS—Immune System—SOCS1—psoriasis	4.08e-05	0.00187	CbGpPWpGaD
SIMEPREVIR—ALB—SLC-mediated transmembrane transport—CP—psoriasis	4.03e-05	0.00185	CbGpPWpGaD
SIMEPREVIR—ALB—Vitamin B12 Metabolism—NFKB1—psoriasis	4.02e-05	0.00185	CbGpPWpGaD
SIMEPREVIR—CTSS—Innate Immune System—TYK2—psoriasis	3.94e-05	0.00181	CbGpPWpGaD
SIMEPREVIR—ALB—Folate Metabolism—IFNG—psoriasis	3.93e-05	0.00181	CbGpPWpGaD
SIMEPREVIR—SLCO1B1—Metabolism—NDUFA5—psoriasis	3.86e-05	0.00177	CbGpPWpGaD
SIMEPREVIR—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IFNG—psoriasis	3.67e-05	0.00169	CbGpPWpGaD
SIMEPREVIR—CTSS—Immune System—CD8A—psoriasis	3.61e-05	0.00166	CbGpPWpGaD
SIMEPREVIR—SLCO1B1—Metabolism of lipids and lipoproteins—CARM1—psoriasis	3.6e-05	0.00165	CbGpPWpGaD
SIMEPREVIR—SLCO1B1—Transmembrane transport of small molecules—CP—psoriasis	3.59e-05	0.00165	CbGpPWpGaD
SIMEPREVIR—CTSS—Innate Immune System—CD4—psoriasis	3.56e-05	0.00164	CbGpPWpGaD
SIMEPREVIR—CTSS—Immune System—HLA-B—psoriasis	3.48e-05	0.0016	CbGpPWpGaD
SIMEPREVIR—CTSS—Adaptive Immune System—CD4—psoriasis	3.42e-05	0.00157	CbGpPWpGaD
SIMEPREVIR—SLCO1B1—Transmembrane transport of small molecules—CARM1—psoriasis	3.42e-05	0.00157	CbGpPWpGaD
SIMEPREVIR—SLCO1B1—Metabolism—CYP2S1—psoriasis	3.28e-05	0.00151	CbGpPWpGaD
SIMEPREVIR—ALB—Folate Metabolism—NFKB1—psoriasis	3.27e-05	0.0015	CbGpPWpGaD
SIMEPREVIR—CTSS—Immune System—HLA-A—psoriasis	3.22e-05	0.00148	CbGpPWpGaD
SIMEPREVIR—CTSS—Innate Immune System—JUN—psoriasis	3.19e-05	0.00147	CbGpPWpGaD
SIMEPREVIR—CYP1A2—Aryl Hydrocarbon Receptor Pathway—JUN—psoriasis	3.18e-05	0.00146	CbGpPWpGaD
SIMEPREVIR—ALB—Vitamin B12 Metabolism—TNF—psoriasis	3.13e-05	0.00144	CbGpPWpGaD
SIMEPREVIR—ALB—Selenium Micronutrient Network—IFNG—psoriasis	3.13e-05	0.00144	CbGpPWpGaD
SIMEPREVIR—CTSS—Immune System—CRP—psoriasis	3.07e-05	0.00141	CbGpPWpGaD
SIMEPREVIR—CTSS—Innate Immune System—NFKB1—psoriasis	3.07e-05	0.00141	CbGpPWpGaD
SIMEPREVIR—CYP1A2—Aryl Hydrocarbon Receptor—NFKB1—psoriasis	3.06e-05	0.0014	CbGpPWpGaD
SIMEPREVIR—ABCB1—Allograft Rejection—IFNG—psoriasis	2.99e-05	0.00137	CbGpPWpGaD
SIMEPREVIR—ABCB1—HIF-1-alpha transcription factor network—JUN—psoriasis	2.98e-05	0.00137	CbGpPWpGaD
SIMEPREVIR—CTSS—Adaptive Immune System—NFKB1—psoriasis	2.95e-05	0.00135	CbGpPWpGaD
SIMEPREVIR—CTSS—Immune System—HLA-DRB1—psoriasis	2.94e-05	0.00135	CbGpPWpGaD
SIMEPREVIR—CTSS—Immune System—ICAM1—psoriasis	2.83e-05	0.0013	CbGpPWpGaD
SIMEPREVIR—CTSS—Immune System—NFKBIA—psoriasis	2.8e-05	0.00129	CbGpPWpGaD
SIMEPREVIR—ABCB1—Allograft Rejection—CXCL8—psoriasis	2.78e-05	0.00127	CbGpPWpGaD
SIMEPREVIR—CYP1A2—Aryl Hydrocarbon Receptor—VEGFA—psoriasis	2.77e-05	0.00127	CbGpPWpGaD
SIMEPREVIR—ABCB1—HIF-1-alpha transcription factor network—VEGFA—psoriasis	2.6e-05	0.0012	CbGpPWpGaD
SIMEPREVIR—ALB—Selenium Micronutrient Network—NFKB1—psoriasis	2.6e-05	0.00119	CbGpPWpGaD
SIMEPREVIR—ALB—Platelet degranulation—VEGFA—psoriasis	2.55e-05	0.00117	CbGpPWpGaD
SIMEPREVIR—ALB—Folate Metabolism—TNF—psoriasis	2.55e-05	0.00117	CbGpPWpGaD
SIMEPREVIR—ALB—Vitamin B12 Metabolism—IL6—psoriasis	2.53e-05	0.00116	CbGpPWpGaD
SIMEPREVIR—ALB—Hemostasis—ITGAL—psoriasis	2.45e-05	0.00113	CbGpPWpGaD
SIMEPREVIR—ALB—Response to elevated platelet cytosolic Ca2+—VEGFA—psoriasis	2.43e-05	0.00111	CbGpPWpGaD
SIMEPREVIR—CYP1A2—Aryl Hydrocarbon Receptor—TNF—psoriasis	2.38e-05	0.00109	CbGpPWpGaD
SIMEPREVIR—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—psoriasis	2.38e-05	0.00109	CbGpPWpGaD
SIMEPREVIR—CTSS—Immune System—TYK2—psoriasis	2.3e-05	0.00105	CbGpPWpGaD
SIMEPREVIR—ABCB1—Integrated Pancreatic Cancer Pathway—PCNA—psoriasis	2.29e-05	0.00105	CbGpPWpGaD
SIMEPREVIR—ABCB1—Allograft Rejection—VEGFA—psoriasis	2.25e-05	0.00104	CbGpPWpGaD
SIMEPREVIR—ALB—Folate Metabolism—TP53—psoriasis	2.24e-05	0.00103	CbGpPWpGaD
SIMEPREVIR—ALB—Metabolism—NDUFA5—psoriasis	2.2e-05	0.00101	CbGpPWpGaD
SIMEPREVIR—CTSS—Immune System—IFNG—psoriasis	2.15e-05	0.000987	CbGpPWpGaD
SIMEPREVIR—CTSS—Immune System—CD4—psoriasis	2.08e-05	0.000954	CbGpPWpGaD
SIMEPREVIR—ALB—Metabolism of lipids and lipoproteins—CARM1—psoriasis	2.06e-05	0.000944	CbGpPWpGaD
SIMEPREVIR—ALB—Folate Metabolism—IL6—psoriasis	2.05e-05	0.000944	CbGpPWpGaD
SIMEPREVIR—ALB—Transmembrane transport of small molecules—CP—psoriasis	2.05e-05	0.000941	CbGpPWpGaD
SIMEPREVIR—ALB—Selenium Micronutrient Network—TNF—psoriasis	2.02e-05	0.000929	CbGpPWpGaD
SIMEPREVIR—ALB—Transmembrane transport of small molecules—CARM1—psoriasis	1.95e-05	0.000898	CbGpPWpGaD
SIMEPREVIR—ABCB1—Allograft Rejection—TNF—psoriasis	1.93e-05	0.000887	CbGpPWpGaD
SIMEPREVIR—ABCB1—Metabolism—NDUFA5—psoriasis	1.93e-05	0.000887	CbGpPWpGaD
SIMEPREVIR—CTSS—Innate Immune System—IL6—psoriasis	1.93e-05	0.000885	CbGpPWpGaD
SIMEPREVIR—ABCB1—Integrated Pancreatic Cancer Pathway—NFKBIA—psoriasis	1.92e-05	0.000882	CbGpPWpGaD
SIMEPREVIR—ALB—Metabolism—CYP2S1—psoriasis	1.87e-05	0.000861	CbGpPWpGaD
SIMEPREVIR—CTSS—Immune System—JUN—psoriasis	1.86e-05	0.000854	CbGpPWpGaD
SIMEPREVIR—ABCB1—Transmembrane transport of small molecules—CP—psoriasis	1.8e-05	0.000825	CbGpPWpGaD
SIMEPREVIR—CTSS—Immune System—NFKB1—psoriasis	1.79e-05	0.000822	CbGpPWpGaD
SIMEPREVIR—SLCO1B1—Metabolism of lipids and lipoproteins—APOE—psoriasis	1.72e-05	0.00079	CbGpPWpGaD
SIMEPREVIR—ABCB1—Transmembrane transport of small molecules—CARM1—psoriasis	1.71e-05	0.000787	CbGpPWpGaD
SIMEPREVIR—ABCB1—Metabolism—CYP2S1—psoriasis	1.64e-05	0.000754	CbGpPWpGaD
SIMEPREVIR—ALB—Selenium Micronutrient Network—IL6—psoriasis	1.63e-05	0.00075	CbGpPWpGaD
SIMEPREVIR—CTSS—Immune System—STAT3—psoriasis	1.61e-05	0.000738	CbGpPWpGaD
SIMEPREVIR—SLCO1B1—Metabolism—CARM1—psoriasis	1.6e-05	0.000736	CbGpPWpGaD
SIMEPREVIR—CYP1A2—Metabolism—NDUFA5—psoriasis	1.54e-05	0.000708	CbGpPWpGaD
SIMEPREVIR—SLCO1B1—Metabolism of lipids and lipoproteins—PPARG—psoriasis	1.5e-05	0.000688	CbGpPWpGaD
SIMEPREVIR—CYP1A2—Metabolism of lipids and lipoproteins—CARM1—psoriasis	1.44e-05	0.00066	CbGpPWpGaD
SIMEPREVIR—CYP1A2—Metabolism—CYP2S1—psoriasis	1.31e-05	0.000602	CbGpPWpGaD
SIMEPREVIR—ABCB1—Integrated Pancreatic Cancer Pathway—JUN—psoriasis	1.27e-05	0.000585	CbGpPWpGaD
SIMEPREVIR—ABCB1—Integrated Pancreatic Cancer Pathway—NFKB1—psoriasis	1.23e-05	0.000563	CbGpPWpGaD
SIMEPREVIR—CYP3A4—Metabolism—NDUFA5—psoriasis	1.19e-05	0.000547	CbGpPWpGaD
SIMEPREVIR—ALB—Platelet activation, signaling and aggregation—VEGFA—psoriasis	1.13e-05	0.000519	CbGpPWpGaD
SIMEPREVIR—CTSS—Immune System—IL6—psoriasis	1.12e-05	0.000516	CbGpPWpGaD
SIMEPREVIR—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—psoriasis	1.11e-05	0.000511	CbGpPWpGaD
SIMEPREVIR—CYP3A4—Metabolism—CYP2S1—psoriasis	1.01e-05	0.000465	CbGpPWpGaD
SIMEPREVIR—ALB—Hemostasis—NOS2—psoriasis	1.01e-05	0.000462	CbGpPWpGaD
SIMEPREVIR—SLCO1B1—Metabolism—CAT—psoriasis	9.85e-06	0.000453	CbGpPWpGaD
SIMEPREVIR—ALB—Metabolism of lipids and lipoproteins—APOE—psoriasis	9.82e-06	0.000451	CbGpPWpGaD
SIMEPREVIR—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—psoriasis	9.53e-06	0.000438	CbGpPWpGaD
SIMEPREVIR—ALB—Metabolism—CARM1—psoriasis	9.15e-06	0.00042	CbGpPWpGaD
SIMEPREVIR—ALB—Metabolism of lipids and lipoproteins—PPARG—psoriasis	8.56e-06	0.000393	CbGpPWpGaD
SIMEPREVIR—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—psoriasis	8.41e-06	0.000386	CbGpPWpGaD
SIMEPREVIR—ABCB1—Metabolism—CARM1—psoriasis	8.02e-06	0.000368	CbGpPWpGaD
SIMEPREVIR—SLCO1B1—Metabolism—APOE—psoriasis	7.66e-06	0.000352	CbGpPWpGaD
SIMEPREVIR—CYP1A2—Metabolism of lipids and lipoproteins—APOE—psoriasis	6.87e-06	0.000316	CbGpPWpGaD
SIMEPREVIR—SLCO1B1—Metabolism—PPARG—psoriasis	6.67e-06	0.000306	CbGpPWpGaD
SIMEPREVIR—CYP1A2—Metabolism—CARM1—psoriasis	6.4e-06	0.000294	CbGpPWpGaD
SIMEPREVIR—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—psoriasis	5.98e-06	0.000275	CbGpPWpGaD
SIMEPREVIR—ALB—Hemostasis—VEGFA—psoriasis	5.82e-06	0.000268	CbGpPWpGaD
SIMEPREVIR—ALB—Metabolism—CAT—psoriasis	5.63e-06	0.000259	CbGpPWpGaD
SIMEPREVIR—CYP3A4—Metabolism—CARM1—psoriasis	4.94e-06	0.000227	CbGpPWpGaD
SIMEPREVIR—ABCB1—Metabolism—CAT—psoriasis	4.93e-06	0.000227	CbGpPWpGaD
SIMEPREVIR—ALB—Hemostasis—TP53—psoriasis	4.4e-06	0.000202	CbGpPWpGaD
SIMEPREVIR—ALB—Metabolism—APOE—psoriasis	4.37e-06	0.000201	CbGpPWpGaD
SIMEPREVIR—CYP1A2—Metabolism—CAT—psoriasis	3.94e-06	0.000181	CbGpPWpGaD
SIMEPREVIR—ABCB1—Metabolism—APOE—psoriasis	3.83e-06	0.000176	CbGpPWpGaD
SIMEPREVIR—ALB—Metabolism—PPARG—psoriasis	3.81e-06	0.000175	CbGpPWpGaD
SIMEPREVIR—ABCB1—Metabolism—PPARG—psoriasis	3.34e-06	0.000153	CbGpPWpGaD
SIMEPREVIR—CYP1A2—Metabolism—APOE—psoriasis	3.06e-06	0.000141	CbGpPWpGaD
SIMEPREVIR—CYP3A4—Metabolism—CAT—psoriasis	3.04e-06	0.00014	CbGpPWpGaD
SIMEPREVIR—CYP1A2—Metabolism—PPARG—psoriasis	2.67e-06	0.000122	CbGpPWpGaD
SIMEPREVIR—CYP3A4—Metabolism—APOE—psoriasis	2.36e-06	0.000108	CbGpPWpGaD
SIMEPREVIR—CYP3A4—Metabolism—PPARG—psoriasis	2.06e-06	9.45e-05	CbGpPWpGaD
